#United States #New York #Securities Fraud #Levi Korsinsky #Picard Medical

Levi & Korsinsky Class Action Alert for Picard Medical Investors

Levi & Korsinsky, LLP has recently issued an important notice for investors of Picard Medical, Inc. (NYSE: PMI). The deadline to apply as a lead plaintiff in a class action lawsuit is approaching on April 3, 2026. This lawsuit is crucial for investors who were harmed due to alleged securities fraud during the period from September 2 to October 31, 2025.

Background of the Lawsuit

The class action lawsuit aims to recover losses suffered by investors who fell victim to a scheme involving fraudulent information spread through social media. The allegations suggest that inside sources participated in a stock promotion scheme that manipulated the stock price of Picard Medical for their benefit. Key points of contention include:

• - False Statements: Allegations indicate that the company made misleading statements and failed to disclose significant information about the manipulative practices that inflated the stock value.
• - Impersonation and Misinformation: It has been claimed that individuals impersonating financial professionals contributed to the misinformation, misleading actual and potential investors about the company’s stability.
• - Concealed Activities: Insiders reportedly utilized offshore accounts to offload shares amid a fabricated rise in stock prices, further jeopardizing the investments of unsuspecting shareholders.

What Investors Should Know

The lawsuit represents a significant opportunity for affected investors to recover their losses. If you suffered a financial setback due to the circumstances outlined above, it is critical to consider participating in this class action. You have until April 3, 2026, to ask the court to appoint you as a lead plaintiff.

Levi & Korsinsky assures potential participants that there are no costs or fees attributed to initiating or navigating this process. Compensation may be accessible without upfront costs, making this a risk-free opportunity for class members.

Why Choose Levi & Korsinsky?

With over two decades of experience in protecting shareholders, Levi & Korsinsky has a proven track record of securing substantial settlements in high-stakes cases. The firm’s dedication to investors is evident through their extensive expertise in securities litigation, backed by a robust team of over 70 professionals committed to client advocacy.

Ranked as one of the top securities litigation firms in the U.S. for seven consecutive years by ISS Securities Class Action Services, Levi & Korsinsky is well-equipped to navigate the complexities of this case.

If you are a Picard Medical investor affected by these events, do not hesitate to reach out to the firm. You can contact Joseph E. Levi, Esq. via email at [email protected] or by phone at (212) 363-7500 for more information.

Conclusion

As the deadline approaches, it is vital for investors to stay informed and take action. This class action could be a significant avenue for restitution for those who experienced losses due to the alleged fraud at Picard Medical, Inc. Engaging with Levi & Korsinsky could provide the necessary support for navigating this complex legal landscape effectively.